University of California San Francisco
Helen Diller Family Comprehensive Cancer Center
Anu Agrawal, MD

Anu Agrawal, MD

Associate Professor of Clinical Pediatrics, UCSF

Cancer Center Program Memberships

Pediatric Malignancies


  • University of Texas at Austin, BA, 12/98, Liberal Arts
  • University of Texas at Austin, BS, 12/98, Mechanical Engineering
  • Baylor College of Medicine, MD, 05/04, Medicine
  • Children’s Hospital and Research Center Oakland, 06/07, Pediatrics
  • Children’s Hospital and Research Center Oakland, 06/11, Pediatric Hematology/Oncology

Honors & Awards

  • 2000
    Baylor Presidential Scholar
  • 2003
    Honorable Mention, Eppswright Award for Outstanding Research in Orthopedic Surgery
  • 2008-2009
    Children's Hospital and Research Center Oakland Pediatric Housestaff Teaching Award
  • 2009
    American Society of Hematology Travel Award
  • 2019-2020
    UCSF Resource Allocation Program Award: Evaluating the feasibility of hospital-based registries to characterize pediatric malignancies in Vietnam
  • 2019-2020
    Cancer League Award: Pharmacokinetics and pharmacogenomics of pediatric cancer therapeutics

Selected Publications

  1. Agrawal AK, Chang PP, Feusner J. Twice weekly Pneumocystis jiroveci prophylaxis with trimethoprim-sulfamethoxazole in pediatric patients with acute lymphoblastic leukemia. J Pediatr Hematol Oncol 2011;33:e1-e4.
  2. Agrawal AK, Saini N, Gildengorin G, Feusner JH. Is routine computed tomographic scanning justified in the first week of persistent febrile neutropenia in children with malignancies? Pediatr Blood Cancer 2011;57:620-624.
  3. Agrawal AK, Feusner JH. Management of tumour lysis syndrome in children: what is the evidence for rasburicase in non-hyperleucocytic leukaemia? Brit J Haematol 2011;153:275-277.
  4. Anglemyer A, Agrawal AK, Rutherford GW. Treatment of Kaposi sarcoma in children with HIV-1 infection. Cochrane Sys Database Rev 2014;1:CD009826.
  5. Reddy-Holdcraft S, Mehta PS, Agrawal AK. Paclitaxel for relapsed or recurrent HIV-associated pediatric Kaposi sarcoma [correspondence]. AIDS 2014;28:800-802.
  6. El-Mallawany NK, Kamiyango W, Villiera J et al. Proposal of a risk-stratification platform to address distinct clinical features of pediatric Kaposi sarcoma in Lilongwe, Malawi. J Glob Oncol 2018;1-7.
  7. Slone J, Slone A, Oaitse W et al. Advancing pediatric oncology in Botswana: a report from the Botswana Pediatric Oncology Database. J Glob Oncol 2018;4:1-9;doi: 10.1200/JGO.17.00095.
  8. Agrawal AK, Bonilla-Aguilar A, Feusner J. Unifying the diagnosis of isolated central nervous system relapse in acute lymphoblastic leukemia based on minimal residual disease testing. Br J Haematol 2019;184:1026-1027.
  9. Pariury H, Wilhoitte J, Michlitsch J, Agrawal AK. Potassium supplementation mitigates corticosteroid-induced neuropsychiatric effects in pediatric oncology patients. J Pediatr Hematol/Oncol 2019;36:445-450.